KDAugust 8, 2026 at 3:04 PM UTCSoftware & Services

Kyndryl Q1 Revenue Slips 3%, but Unchanged Full-Year Outlook Keeps Turnaround Narrative Alive

Read source article

What happened

Kyndryl reported fiscal first-quarter revenue of $3.6 billion, down 3% from the prior year as deliberate pruning of low-margin contracts and extended sales cycles continued to weight on the top line. Management maintained its full-year guidance for constant-currency revenue growth and approximately $550 million in free cash flow, signaling confidence that a record $34 billion backlog and strong signings will drive a second-half ramp. Growth in consulting, hyperscaler partnerships, and AI-led modernization services advanced the mix shift toward higher-margin offerings despite the headline decline. The result fits the pattern of a bumpy but improving turnaround where margin expansion and cash generation remain the primary levers for value creation. The key test now is whether the promised second-half conversion of backlog into reported growth materializes to validate the investment thesis.

Implication

The 3% revenue decline mirrors the pattern of the prior fiscal year’s first half and reflects ongoing management actions to shed low-quality third-party content, not a demand shortfall. Reiteration of full-year targets for modest top-line growth and ~$550 million in free cash flow suggests that the company’s large backlog and record signings are expected to convert into revenue in the second half, keeping the investment thesis intact. At roughly 11x trailing earnings and 5.5x EV/EBITDA, the market already prices in top-line sluggishness, offering a potential discount if execution unfolds as planned. However, repeated delays in achieving clean revenue growth could erode patience and re-rate the stock toward a value-trap multiple. Investors should monitor sequential quarterly revenue trends and signings momentum closely for signs that the hoped-for inflection is truly underway.

Thesis delta

The Q1 revenue slip is consistent with the previously identified bumpy path and does not alter the core thesis that Kyndryl’s margin improvement and backlog conversion will eventually drive shareholder returns. Unchanged full-year guidance reinforces confidence in the underlying cash generation and margin story, though the exact timing of the revenue growth inflection remains uncertain.

Confidence

Medium